PTP
AMRX icon

Platform Technology Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Platform Technology Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,250
Closed -$63K – 204
2020
Q2 		$63K Buy
+13,250
New +$54.6K 0.04% 189

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Platform Technology Partners's AMRX Position: Q3 2020 in Review

Platform Technology Partners sold out of Amneal Pharmaceuticals (AMRX) in Q3 2020, closing a stake of 13,250 shares — an estimated $63K sold.

Platform Technology Partners first reported a position in AMRX in Q2 2020 and held it in 1 quarter. The position peaked at $63K in Q2 2020. 140 funds tracked by Wall St. Rank hold AMRX as of Q3 2020.

  • Platform Technology Partners reported no remaining Amneal Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Platform Technology Partners sold 13,250 Amneal Pharmaceuticals shares in Q3 2020, an estimated $63K.
  • Platform Technology Partners first reported a position in Amneal Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Platform Technology Partners's Amneal Pharmaceuticals position peaked at $63K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2020.

Based on Platform Technology Partners's 13F filing for Q3 2020, filed 30 Nov 2020.